Repeatability of the timed 25-foot walk test for individuals with multiple sclerosis

Clinical Rehabilitation

Volumn 27, Issue 8, 2013, Pages 719-723

  Larson, Rebecca D ^a,b   Larson, Daniel J ^a,b   Baumgartner, Ted B ^a   White, Lesley J ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

assessment; clinical tests; mobility; Multiple sclerosis; repeatability

Indexed keywords

DISABILITY; EXERCISE TEST; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PATHOPHYSIOLOGY; PHYSIOLOGY; REPRODUCIBILITY; STANDARDS; TIME; VALIDATION STUDY; WALKING; ARTICLE; ASSESSMENT; CLINICAL TESTS; MOBILITY; MULTIPLE SCLEROSIS; REPEATABILITY; STANDARD;

DISABILITY EVALUATION; EXERCISE TEST; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; REPRODUCIBILITY OF RESULTS; TIME FACTORS; WALKING;

ASSESSMENT; CLINICAL TESTS; MOBILITY; MULTIPLE SCLEROSIS; REPEATABILITY;

EID: 84880159270     PISSN: 02692155     EISSN: 14770873     Source Type: Journal    
DOI: 10.1177/0269215512470269     Document Type: Article

References (25)

1. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 ; 33 (11). 1444-1452 (Pubitemid 14237132)
2. Noseworthy JH. Clinical scoring methods for multiple sclerosis. Ann Neurol. 1994 ;: S80-85
3. Hobart J, Freeman J, Thompson A. Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain. 2000 ; 123 (Pt 5). 1027-1040 (Pubitemid 30224198)
4. Sharrack B, Hughes RA, Soudain S, Dunn G. The psychometric properties of clinical rating scales used in multiple sclerosis. Brain. 1999 ; 122 (Pt 1). 141-159 (Pubitemid 29046280)
5. Whitaker JN, McFarland HF, Rudge P, Reingold SC. Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Mult Scler. 1995 ; 1 (1). 37-47
6. Kaufman M, Moyer D, Norton J. The significant change for the Timed 25-foot Walk in the multiple sclerosis functional composite. Mult Scler. 2000 ; 6 (4). 286-290
7. Rudick R, Antel J, Confavreux C, et al. Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol. 1997 ; 42 (3). 379-382 (Pubitemid 127744543)
8. Rudick R, Antel J, Confavreux C, et al. Clinical outcomes assessment in multiple sclerosis. Ann Neurol. 1996 ; 40 (3). 469-479 (Pubitemid 26304809)
9. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler. 1999 ; 5 (4). 244-250 (Pubitemid 29405620)
10. Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain. 1999 ; 122 (Pt 5). 871-882 (Pubitemid 29219261)
11. Cohen JA, Cutter GR, Fischer JS, et al. Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. Arch Neurol. 2001 ; 58 (6). 961-967 (Pubitemid 32537471)
12. Soilu-Hanninen M, Aivo J, Lindstrom BM, et al. A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon beta-1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2012 ; 83 (5). 565-571
13. Spain RI, St George RJ, Salarian A, et al. Body-worn motion sensors detect balance and gait deficits in people with multiple sclerosis who have normal walking speed. Gait Posture. 2012 ; 35 (4). 573-578
14. Gijbels D, Dalgas U, Romberg A, et al. Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set. Mult Scler. 2012 ; 18 (3). 364-371
15. Broekmans T, Roelants M, Feys P, et al. Effects of long-term resistance training and simultaneous electro-stimulation on muscle strength and functional mobility in multiple sclerosis. Mult Scler. 2011 ; 17 (4). 468-477
16. Bosma LV, Kragt JJ, Knol DL, Polman CH, Uitdehaag BM. Clinical scales in progressive MS: predicting long-term disability. Mult Scler. 2012 ; 18 (3). 345-350
17. Phan-Ba R, Pace A, Calay P, et al. Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis. Neurorehabil Neural Repair. 2011 ; 25 (7). 672-679
18. Ratchford JN, Shore W, Hammond ER, et al. A pilot study of functional electrical stimulation cycling in progressive multiple sclerosis. Neuro Rehabilitation. 2010 ; 27 (2). 121-128
19. Widener GL, Allen DD, Gibson-Horn C. Balance-based torso-weighting may enhance balance in persons with multiple sclerosis: preliminary evidence. Arch Phys Med Rehabil. 2009 ; 90 (4). 602-609
20. Sutliff MH, Naft JM, Stough DK, Lee JC, Arrigain SS, Bethoux FA. Efficacy and safety of a hip flexion assist orthosis in ambulatory multiple sclerosis patients. Arch Phys Med Rehabil. 2008 ; 89 (8). 1611-1617
21. Ytterberg C, Johansson S, Andersson M, Widen Holmqvist L, von Koch L. Variations in functioning and disability in multiple sclerosis. A two-year prospective study. J Neurol. 2008 ; 255 (7). 967-973
22. Solari A, Radice D, Manneschi L, Motti L, Montanari E. The multiple sclerosis functional composite: different practice effects in the three test components. J Neurol Sci. 2005 ; 228 (1). 71-74 (Pubitemid 39656497)
23. Schwid SR, Goodman AD, McDermott MP, Bever CF, Cook SD. Quantitative functional measures in MS: what is a reliable change?. Neurology. 2002 ; 58 (8). 1294-1296 (Pubitemid 34411881)
24. Rudick RA, Cutter G, Reingold S. The multiple sclerosis functional composite: a new clinical outcome measure for multiple sderosis trials. Mult Scler. 2002 ; 8 (5). 359-365
25. Rosti-Otajarvi E, Hamalainen P, Koivisto K, Hokkanen L. The reliability of the MSFC and its components. Acta Neurol Scand. 2008 ; 117 (6). 421-427 (Pubitemid 351643674)